Why the sarcasm? I actually thought you were a bit better than...

First 64 Last

Share
Profile

Follow
arryd

375 Posts.

1

08/12/15

07:57

Post #: 16565681
Share

Originally posted by OllieB ↑

I think $2-2.20 is the next major technical support. But whether it hits that or bounces from that level, who knows!! The trend is clearly down at the moment though.

Given there are no earnings or cashflow etc is $1bn cheap, $400m cheap, $200 cheap, $10m cheap? Who knows.

What we do know for sure is the last P&L showed the biggest revenue line was an fx gain and the biggest expense was employee benefits and share based payments.

But don't worry it will be earning billions soon enough, because the concept makes sense and Joanna said so (I know I don't get it).

Good luck to all.

Expand

Why the sarcasm? I actually thought you were a bit better than the others that come on here who have a negative view on 1PG, but no you arrogantly dismiss it like all the others who think they know everything about the company and its future.

Is it a crime to believe this system will work and its management actually can execute their vision? Just because you dont get it doesnt mean that wont happen. Im so sick of all the nay-sayers coming on here who think its a certainty its going to fail, just because you made a buck on some other companies doesnt mean you know whats going to happen anymore than I do so get over yourselves.

1PG Price at posting: $2.79 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 64 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Why the sarcasm? I actually thought you were a bit better than...

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News